Moderna, Inc. (FRA:0QF)
29.53
+0.54 (1.85%)
At close: Jan 9, 2026
Moderna Revenue
Moderna had revenue of $1.02B USD in the quarter ending September 30, 2025, a decrease of -45.44%. This brings the company's revenue in the last twelve months to $2.23B, down -56.07% year-over-year. In the year 2024, Moderna had annual revenue of $3.24B, down -52.75%.
Revenue (ttm)
$2.23B
Revenue Growth
-56.07%
P/S Ratio
6.06
Revenue / Employee
$384.83K
Employees
5,800
Market Cap
11.52B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
| Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
| Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
| Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
| Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
| Dec 31, 2019 | 60.00M | -75.07M | -55.58% |
| Dec 31, 2018 | 135.07M | -70.76M | -34.38% |
| Dec 31, 2017 | 205.83M | 97.43M | 89.88% |
| Dec 31, 2016 | 108.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
Moderna News
- 2 days ago - Life-saving therapies are being delayed as research funding dries up | Letter - The Guardian
- 4 days ago - Moderna just had its best day since October. Here's what's going on, and what analysts expect - CNBC
- 4 days ago - Moderna Stock Fights Back Against Four‑Year Curse With 20% Blastoff And A Golden Cross - Benzinga
- 4 days ago - UBS Lowers Moderna (MRNA) Price Target to $34, Rating Changed to Neutral | MRNA Stock News - GuruFocus
- 4 days ago - MRNA Crosses Above Average Analyst Target - Nasdaq
- 4 days ago - My Top 5 Stocks to Buy in Early 2026 - The Motley Fool
- 4 days ago - Moderna (MRNA) Soars 10.9%: Is Further Upside Left in the Stock? - Nasdaq
- 4 days ago - Tuesday Sector Leaders: Healthcare, Technology & Communications - Nasdaq